Incidence and the clinical outcomes of epidermal growth factor receptor (EGFR) mutations in male smokers with squamous cell carcinoma of lung

2008 ◽  
Vol 6 (9) ◽  
pp. 111-112
Author(s):  
S. Park ◽  
E. Cho ◽  
D. Shin
Keyword(s):  
Squamous Cell Carcinoma ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Cell Carcinoma ◽  
Clinical Outcomes ◽  
Squamous Cell ◽  
Growth Factor Receptor ◽  
Egfr Mutations ◽  
Epidermal Growth

Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis

2017 ◽  
Vol 61 ◽  
pp. 97-104 ◽  
Author(s):  
Alice Muglia Thomaz da Silva Amancio ◽  
Isabela Werneck da Cunha ◽  
José Ivanildo Neves ◽  
Josiane da Silva Quetz ◽  
Dirce Maria Carraro ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Growth Factor Receptor ◽  
Epidermal Growth ◽  
Survival Predictor

scholarly journals β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma

2020 ◽  
Vol 16 (3) ◽  
pp. 195-209 ◽  
Author(s):  
Kevin Brown Chandler ◽  
Khalid A. Alamoud ◽  
Vanessa L. Stahl ◽  
Bach-Cuc Nguyen ◽  
Vinay K. Kartha ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Oral Cancer ◽  
Epidermal Growth Factor ◽  
Oral Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Growth Factor Receptor ◽  
Epidermal Growth

Genomic and structural analyses reveal that β-catenin/CBP signaling represses epidermal growth factor receptor (EGFR) N-glycan antennary fucosylation in oral cancer.

Sign in / Sign up

Export Citation Format

Share Document